Shilpa Medicare Ltd - 530549 - Board declares Interim Dividend
Shilpa Medicare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 06, 2020 have declared an interim dividend @110% i.e. Rs. 1.10/- (Rupees One Rupee Ten Paisa Only) per equity share bearing nominal value Re. 1.00/- (Rupee One Only) for the Financial Year 2019-20. Shilpa Medicare Ltd - 530549 - Sub: Intimation Of Record Date For Interim Dividend - Reg. Ref: Regulation 42 Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015; Scrip Code: BSE - 530549/ Stock Symbol: NSE - SHILPAMED
With reference to the captioned subject, please note that the Board of Directors at their meeting held on 06.03.2020 have declared an interim dividend @ 110% i.e. Rs. 1.10/- (Rupees One Rupee Ten Paisa Only) per equity share bearing nominal value Re. 1.00/- (Rupee One Only) ) for the Financial Year 2019-20. In relation thereto, the Record Date for the aforementioned transaction, as required under Regulation 42 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 is as follows: Nature of Security Record Date Purpose Equity Shares of Re.1/- each 17.03.2020 Payment of Interim dividend. This is for your information and necessary records. SHILPA MEDICARE LTD. - 530549 - Sub: Outcome Of Board Meeting - Reg. Ref: Regulation 30 Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015; Scrip Code: BSE - 530549/ Stock Symbol: NSE - SHILPAMED
With reference to the captioned subject, please note that the Board of Directors at their meeting held on 06.03.2020 have declared an interim dividend @ 110% i.e. Rs. 1.10/- (Rupees One Rupee Ten Paisa Only) per equity share bearing nominal value Re. 1.00/- (Rupee One Only) for the Financial Year 2019-20. It is further intimated that meeting commenced at 11:00 A.M. and concluded at 11:30 A.M. This is for your information and necessary records. SHILPA MEDICARE LTD. - 530549 - Corporate Action-Board to consider Dividend
Dear Sir, With reference to the subject cited above, we wish to inform you that a Meeting of the Board of Directors of the Company will be held on 06.03.2020, inter alia to consider declaration of interim dividend for the financial year ended 31.03.2020. It is further informed that if interim dividend is declared at the upcoming board meeting, the RECORD DATE will be as follows: Nature of Security Record Date Purpose Equity Shares of Re.1/- each 17.03.2020 Payment of Interim dividend. It is further informed that in pursuance of the Company's Code of Conduct and in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 the trading window of the Company would be closed from 04.03.2020 till 08.03.2020 (Both days inclusive). This is for your information and records. SHILPA MEDICARE LTD. - 530549 - Sub: Intimation Of Board Meeting Under Regulation 29 And Record Date Under Regulation 42 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
Dear Sir, With reference to the subject cited above, we wish to inform you that a Meeting of the Board of Directors of the Company will be held on 06.03.2020, inter alia to consider declaration of interim dividend for the financial year ended 31.03.2020. It is further informed that if interim dividend is declared at the upcoming board meeting, the RECORD DATE will be as follows: Nature of Security Record Date Purpose Equity Shares of Re.1/- each 17.03.2020 Payment of Interim dividend. It is further informed that in pursuance of the Company's Code of Conduct and in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 the trading window of the Company would be closed from 04.03.2020 till 08.03.2020 (Both days inclusive). This is for your information and records. SHILPA MEDICARE LTD. - 530549 - Closure of Trading Window
Dear Sir, With reference to the subject cited above, we wish to inform you that a Meeting of the Board of Directors of the Company will be held on 06.03.2020, inter alia to consider declaration of interim dividend for the financial year ended 31.03.2020. It is further informed that if interim dividend is declared at the upcoming board meeting, the RECORD DATE will be as follows: Nature of Security Record Date Purpose Equity Shares of Re.1/- each 17.03.2020 Payment of Interim dividend. It is further informed that in pursuance of the Company's Code of Conduct and in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 the trading window of the Company would be closed from 04.03.2020 till 08.03.2020 (Both days inclusive). This is for your information and records. Shilpa Medicare Ltd - 530549 - Board Meeting Intimation for Sub: Intimation Of Board Meeting Under Regulation 29 And Record Date Under Regulation 42 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015. Ref.: Scrip Code: BSE: 530549 & NSE: SHILPAMED
SHILPA MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/03/2020 ,inter alia, to consider and approve Dear Sir, With reference to the subject cited above, we wish to inform you that a Meeting of the Board of Directors of the Company will be held on 06.03.2020, inter alia to consider declaration of interim dividend for the financial year ended 31.03.2020. It is further informed that if interim dividend is declared at the upcoming board meeting, the RECORD DATE will be as follows: Nature of Security Record Date Purpose Equity Shares of Re.1/- each 17.03.2020 Payment of Interim dividend. It is further informed that in pursuance of the Company's Code of Conduct and in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 the trading window of the Company would be closed from 04.03.2020 till 08.03.2020 (Both days inclusive). This is for your information and records. Thanking you, SHILPA MEDICARE LTD. - 530549 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd acting as Pledgee (Security Trustee) on behalf of Placid Ltd (Lender) SHILPA MEDICARE LTD. - 530549 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 29, 2020 for Ramakant Inani SHILPA MEDICARE LTD. - 530549 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 29, 2020 for Brijgopal Inani